Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer
Open Access
- 31 August 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13539
Abstract
The members of the cytokine interleukin 17 (IL-17) family, along with their receptors (IL-17R), are vital players in a range of inflammatory diseases and cancer. Although generally regarded as proinflammatory, the effects they exhibit on cancer progression are a double-edged sword, with both antitumor and protumor activities being discovered. There is growing evidence that the IL-17 signaling pathways have significant impacts on the tumor microenvironment (TME), immune response, and inflammation in various types of cancer, including pancreatic cancer. However, the detailed mechanistic functions of the IL-17/IL-17R families in pancreatic cancer were rarely systematically elucidated. This review considers the role of the IL-17/IL-17R families in inflammation and tumor immunity and elaborates on the mechanistic functions and correlations of these members with pathogenesis, progression, and chemoresistance in pancreatic cancer. By summarizing the advanced findings on the role of IL-17/IL17R family members and IL-17 signaling pathways at the molecular level, cellular level, and disease level in pancreatic cancer, this review provides an in-depth discussion on the potential of IL-17/IL-17R as prognostic markers and therapeutic targets in pancreatic cancer.Keywords
Funding Information
- Hong Kong General Research Fund (12101018, 12102518, 12100719, RC-IRMS/15-16/01, 2020B1212030006)
- Hong Kong Baptist University (12101018, 12102518, 12100719, RC-IRMS/15-16/01, 2020B1212030006)
- Technology Innovation Strategy Special Fund (12101018, 12102518, 12100719, RC-IRMS/15-16/01, 2020B1212030006)
This publication has 108 references indexed in Scilit:
- High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the SkinPLOS ONE, 2012
- A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303Clinical Cancer Research, 2012
- Signaling of interleukin-17 family cytokines in immunity and inflammationCellular Signalling, 2011
- IL-17RC: a partner in IL-17 signaling and beyondSeminars in Immunopathology, 2009
- Structural basis of receptor sharing by interleukin 17 cytokinesNature Immunology, 2009
- Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 2009
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayJournal of Experimental Medicine, 2009
- Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult miceProceedings of the National Academy of Sciences, 2008
- Regulation of inflammatory responses by IL-17FJournal of Experimental Medicine, 2008